Mirum Pharmaceuticals SG&A Expense (Quarterly) Insights

Mirum Pharmaceuticals Inc (MIRM)

26.39 +0.55 (+2.13%) USD | NASDAQ | May 06, 16:00

26.40 +0.01 (+0.04%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	46.18M
September 30, 2023	36.53M
June 30, 2023	32.95M
March 31, 2023	30.22M
December 31, 2022	26.47M
September 30, 2022	22.51M
June 30, 2022	20.97M
March 31, 2022	19.12M
December 31, 2021	19.04M
September 30, 2021	17.35M
June 30, 2021	13.35M

Date	Value
March 31, 2021	9.479M
December 31, 2020	7.225M
September 30, 2020	5.732M
June 30, 2020	5.042M
March 31, 2020	4.692M
December 31, 2019	4.278M
September 30, 2019	3.708M
June 30, 2019	2.445M
March 31, 2019	1.321M
September 30, 2018	0.062M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.445M

Minimum

Jun 2019

46.18M

Maximum

Dec 2023

17.23M

Average

17.35M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks